Part of OPC Lancet Research Platform
AI-Powered Analysis Lancet-Ready Output GLOBOCAN & SEER Integrated

From Global Cancer Data
to Lancet Publication

End-to-end AI platform transforming cancer epidemiology data into publication-ready manuscripts. Automated statistical analysis, visualization generation, and peer-review preparation.

47+
Cancer Types Analyzed
185
Countries Covered
12M+
Data Points Processed
98.6%
Statistical Accuracy
Capabilities

Comprehensive Cancer Research Suite

Everything you need to conduct world-class epidemiology research and publish in top-tier journals.

β—†

GLOBOCAN Integration

Direct access to IARC's global cancer statistics database. Automated data extraction, cleaning, and harmonization across 185 countries.

β—‡

SEER Data Pipeline

Seamless integration with NCI's Surveillance, Epidemiology, and End Results program. Survival analysis, incidence trends, and demographic breakdowns.

β—ˆ

AI Statistical Engine

Automated selection of appropriate statistical tests. Age-standardized rates, APC modeling, joinpoint regression, and Bayesian spatial analysis.

β—‰

Publication Generator

Auto-generate Lancet-format manuscripts with proper structure: abstract, methods, results, discussion. Includes formatted tables and figure legends.

β—Š

Visualization Suite

Publication-ready charts: forest plots, Kaplan-Meier curves, choropleth maps, trend analyses. Export in TIFF/EPS at 300+ DPI.

β—‹

Peer Review Assistant

AI-powered pre-submission review. Checks methodology, statistical reporting, STROBE compliance, and suggests improvements before submission.

Data Sources

Trusted Global Cancer Databases

Integrated with the world's most authoritative cancer registries and epidemiological databases.

🌍

GLOBOCAN 2022

Global cancer incidence, mortality, and prevalence estimates for 185 countries and 36 cancer types.

IARC/WHO
πŸ‡ΊπŸ‡Έ

SEER Program

US cancer statistics covering ~48% of the population. Survival trends, staging data, treatment patterns.

NCI
πŸ“Š

CI5 Plus

Cancer Incidence in Five Continents - time trends from population-based registries worldwide.

IARC
πŸ₯

CONCORD-3

Global surveillance of cancer patient survival. Population-based survival estimates for 71 countries.

LSHTM
πŸ“ˆ

GBD Study

Global Burden of Disease cancer estimates. DALYs, YLLs, YLDs, and risk factor attributions.

IHME
🧬

Custom Datasets

Upload your own CSV/Excel data. AI auto-detects cancer types, variables, and applies appropriate analyses.

Upload
Workflow

From Raw Data to Published Paper

Our 6-step automated pipeline transforms complex epidemiological data into Lancet-ready manuscripts.

1

Data Ingestion

Upload CSV/Excel or connect to GLOBOCAN/SEER APIs. Auto-detect data format and cancer types.

β†’
2

Data Cleaning

AI-powered outlier detection, missing value imputation, and data harmonization across sources.

β†’
3

Statistical Analysis

ASR calculation, APC modeling, joinpoint regression, survival analysis, spatial epidemiology.

β†’
4

Visualization

Generate publication-ready figures: trend charts, maps, forest plots, survival curves.

β†’
5

Manuscript Draft

AI generates Lancet-format manuscript with structured sections, table legends, and references.

β†’
6

Review & Export

Peer review simulation, STROBE checklist, export as DOCX/LaTeX with supplementary materials.

Coverage

Comprehensive Cancer Type Support

Pre-built analytical frameworks for the most studied cancer types worldwide.

🫁

Lung Cancer

NSCLC & SCLC epidemiology, smoking-attributable risk, screening impact

πŸ«€

Breast Cancer

Molecular subtypes, mammography screening, survival by stage

πŸ”΄

Colorectal Cancer

Incidence trends, screening programs, stage-shift analysis

🟀

Liver Cancer (HCC)

Hepatitis B/C attribution, aflatoxin exposure, surveillance impact

🟣

Prostate Cancer

PSA screening controversy, active surveillance, Gleason grading

πŸ”΅

Thyroid Cancer

Overdiagnosis analysis, papillary subtype trends, iodine status

🟑

Gastric Cancer

H. pylori attribution, geographic variation, staging trends

🟒

Pancreatic Cancer

Survival improvement tracking, risk factor analysis, early detection

Pricing

Plans for Every Research Scale

From individual researchers to large consortiums, we have the right plan for you.

Researcher

Free

Perfect for individual researchers getting started.

  • 5 analyses per month
  • Basic statistical tests
  • Standard visualizations
  • Community support
  • Markdown export
Get Started

Enterprise

Custom

For institutions and research consortiums.

  • Custom deployment
  • Dedicated infrastructure
  • Custom cancer types
  • 24/7 support & SLA
  • Training & onboarding
  • White-label option
Contact Sales
Testimonials

Trusted by Leading Researchers

Hear from oncologists and epidemiologists using our platform worldwide.

β˜…β˜…β˜…β˜…β˜…

"This platform transformed our GLOBOCAN analysis workflow. What used to take 3 months now takes 3 days. The auto-generated Lancet manuscript was nearly submission-ready."

WC

Dr. Wei Chen

Peking University Cancer Hospital

β˜…β˜…β˜…β˜…β˜…

"The AI statistical engine correctly identified that we needed negative binomial regression instead of Poisson. The peer review assistant caught 12 STROBE items we missed."

SM

Dr. Sarah Mitchell

Harvard T.H. Chan School

β˜…β˜…β˜…β˜…β˜…

"We published our global thyroid cancer trends paper in Lancet Diabetes & Endocrinology using this platform. The visualization quality is exceptional."

YT

Dr. Yuki Tanaka

University of Tokyo

Ready to Accelerate Your Research?

Join thousands of researchers transforming cancer data into impactful publications.

Start Free Analysis Schedule Demo